Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 598

1.

Promoting stigma coping and empowerment in patients with schizophrenia and depression: results of a cluster-RCT.

Gaebel W, Zäske H, Hesse K, Klingberg S, Ohmann C, Grebe J, Kolbe H, Icks A, Schneider F, Backes V, Wolff-Menzler C, Guse B, Gallinat J, Bock T, Jockers-Scherübl MC, Krüger T, Jessen F, Bechdolf A, Kircher T, Konrad C, Falkai P, Schaub A, Rudolph M, Köllner V, Schmid-Ott G, Linden M, Lieberei B, Stuhlinger M, Sommerfeld S, Schumacher A, Krenge S, Gereke S, Mönter N, Navarro-Urena A, Frosch G, Kuhlbusch FJ, Cleveland H, Riesbeck M.

Eur Arch Psychiatry Clin Neurosci. 2019 Sep 13. doi: 10.1007/s00406-019-01064-3. [Epub ahead of print]

PMID:
31520149
2.

Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment.

Steiner J, Frodl T, Schiltz K, Dobrowolny H, Jacobs R, Fernandes BS, Guest PC, Meyer-Lotz G, Borucki K, Bahn S, Bogerts B, Falkai P, Bernstein HG.

Schizophr Bull. 2019 Aug 29. pii: sbz068. doi: 10.1093/schbul/sbz068. [Epub ahead of print]

PMID:
31504969
3.

The genetic relationship between educational attainment and cognitive performance in major psychiatric disorders.

Comes AL, Senner F, Budde M, Adorjan K, Anderson-Schmidt H, Andlauer TFM, Gade K, Hake M, Heilbronner U, Kalman JL, Reich-Erkelenz D, Klöhn-Saghatolislam F, Schaupp SK, Schulte EC, Juckel G, Dannlowski U, Schmauß M, Zimmermann J, Reimer J, Reininghaus E, Anghelescu IG, Arolt V, Baune BT, Konrad C, Thiel A, Fallgatter AJ, Nieratschker V, Figge C, von Hagen M, Koller M, Becker T, Wigand ME, Jäger M, Dietrich DE, Stierl S, Scherk H, Spitzer C, Folkerts H, Witt SH, Degenhardt F, Forstner AJ, Rietschel M, Nöthen MM, Wiltfang J, Falkai P, Schulze TG, Papiol S.

Transl Psychiatry. 2019 Aug 28;9(1):210. doi: 10.1038/s41398-019-0547-x.

4.

Sex Matters: A Multivariate Pattern Analysis of Sex- and Gender-Related Neuroanatomical Differences in Cis- and Transgender Individuals Using Structural Magnetic Resonance Imaging.

Baldinger-Melich P, Urquijo Castro MF, Seiger R, Ruef A, Dwyer DB, Kranz GS, Klöbl M, Kambeitz J, Kaufmann U, Windischberger C, Kasper S, Falkai P, Lanzenberger R, Koutsouleris N.

Cereb Cortex. 2019 Aug 1. pii: bhz170. doi: 10.1093/cercor/bhz170. [Epub ahead of print]

PMID:
31368487
5.

Running effects on cognition and plasticity (ReCaP): study protocol of a longitudinal examination of multimodal adaptations of marathon running.

Roeh A, Bunse T, Lembeck M, Handrack M, Pross B, Schoenfeld J, Keeser D, Ertl-Wagner B, Pogarell O, Halle M, Falkai P, Hasan A, Scherr J.

Res Sports Med. 2019 Jul 25:1-15. doi: 10.1080/15438627.2019.1647205. [Epub ahead of print]

PMID:
31345073
6.

Aerobic exercise in mental disorders: from basic mechanisms to treatment recommendations.

Schmitt A, Reich-Erkelenz D, Hasan A, Falkai P.

Eur Arch Psychiatry Clin Neurosci. 2019 Aug;269(5):483-484. doi: 10.1007/s00406-019-01037-6. No abstract available.

PMID:
31250087
7.

Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia.

Trossbach SV, Hecher L, Schafflick D, Deenen R, Popa O, Lautwein T, Tschirner S, Köhrer K, Fehsel K, Papazova I, Malchow B, Hasan A, Winterer G, Schmitt A, Meyer Zu Hörste G, Falkai P, Korth C.

Transl Psychiatry. 2019 May 31;9(1):156. doi: 10.1038/s41398-019-0486-6.

8.

Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia.

Maurus I, Hasan A, Röh A, Takahashi S, Rauchmann B, Keeser D, Malchow B, Schmitt A, Falkai P.

Eur Arch Psychiatry Clin Neurosci. 2019 Aug;269(5):499-515. doi: 10.1007/s00406-019-01025-w. Epub 2019 May 21. Review.

PMID:
31115660
9.

A new role for oligodendrocytes and myelination in schizophrenia and affective disorders?

Schmitt A, Simons M, Cantuti-Castelvetri L, Falkai P.

Eur Arch Psychiatry Clin Neurosci. 2019 Jun;269(4):371-372. doi: 10.1007/s00406-019-01019-8. No abstract available.

PMID:
31076838
10.

The need to develop personalized interventions to improve cognition in schizophrenia.

Falkai P, Schmitt A.

World Psychiatry. 2019 Jun;18(2):170. doi: 10.1002/wps.20650. No abstract available.

11.

Childhood Trauma in Schizophrenia: Current Findings and Research Perspectives.

Popovic D, Schmitt A, Kaurani L, Senner F, Papiol S, Malchow B, Fischer A, Schulze TG, Koutsouleris N, Falkai P.

Front Neurosci. 2019 Mar 21;13:274. doi: 10.3389/fnins.2019.00274. eCollection 2019. Review.

12.

Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies.

Proebstl L, Kamp F, Manz K, Krause D, Adorjan K, Pogarell O, Koller G, Soyka M, Falkai P, Kambeitz J.

Eur Psychiatry. 2019 Jun;59:15-24. doi: 10.1016/j.eurpsy.2019.03.003. Epub 2019 Apr 11.

PMID:
30981746
13.

Depression in Somatic Disorders: Is There a Beneficial Effect of Exercise?

Roeh A, Kirchner SK, Malchow B, Maurus I, Schmitt A, Falkai P, Hasan A.

Front Psychiatry. 2019 Mar 20;10:141. doi: 10.3389/fpsyt.2019.00141. eCollection 2019.

14.

Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis.

Koutsouleris N, Kambeitz-Ilankovic L, Ruhrmann S, Rosen M, Ruef A, Dwyer DB, Paolini M, Chisholm K, Kambeitz J, Haidl T, Schmidt A, Gillam J, Schultze-Lutter F, Falkai P, Reiser M, Riecher-Rössler A, Upthegrove R, Hietala J, Salokangas RKR, Pantelis C, Meisenzahl E, Wood SJ, Beque D, Brambilla P, Borgwardt S; PRONIA Consortium.

JAMA Psychiatry. 2018 Nov 1;75(11):1156-1172. doi: 10.1001/jamapsychiatry.2018.2165.

PMID:
30942846
15.

The Influence of Continuous Exercising on Chronotropic Incompetence in Multi-Episode Schizophrenia.

Herbsleb M, Keller-Varady K, Wobrock T, Hasan A, Schmitt A, Falkai P, Gabriel HHW, Bär KJ, Malchow B.

Front Psychiatry. 2019 Mar 13;10:90. doi: 10.3389/fpsyt.2019.00090. eCollection 2019.

16.

The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease.

Franzmeier N, Ren J, Damm A, Monté-Rubio G, Boada M, Ruiz A, Ramirez A, Jessen F, Düzel E, Rodríguez Gómez O, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, Buerger K, Levin J, Duering M, Dichgans M, Suárez-Calvet M, Haass C, Gordon BA, Lim YY, Masters CL, Janowitz D, Catak C, Wolfsgruber S, Wagner M, Milz E, Moreno-Grau S, Teipel S, Grothe MJ, Kilimann I, Rossor M, Fox N, Laske C, Chhatwal J, Falkai P, Perneczky R, Lee JH, Spottke A, Boecker H, Brosseron F, Fliessbach K, Heneka MT, Nestor P, Peters O, Fuentes M, Menne F, Priller J, Spruth EJ, Franke C, Schneider A, Westerteicher C, Speck O, Wiltfang J, Bartels C, Araque Caballero MÁ, Metzger C, Bittner D, Salloway S, Danek A, Hassenstab J, Yakushev I, Schofield PR, Morris JC, Bateman RJ, Ewers M.

Mol Psychiatry. 2019 Mar 21. doi: 10.1038/s41380-019-0404-6. [Epub ahead of print]

PMID:
30899092
17.

[When exhaustion becomes a torment - from excessive labour to burn-out].

Palm U, Falkai P.

MMW Fortschr Med. 2019 Mar;161(5):44-46. doi: 10.1007/s15006-019-0273-6. Review. German. No abstract available.

PMID:
30887328
18.

The reliability and clinical utility of ICD-11 schizoaffective disorder: A field trial.

Peterson DL, Webb CA, Keeley JW, Gaebel W, Zielasek J, Rebello TJ, Robles R, Matsumoto C, Kogan CS, Kulygina M, Farooq S, Green MF, Falkai P, Hasan A, Galderisi S, Larach V, Krasnov V, Reed GM.

Schizophr Res. 2019 Jun;208:235-241. doi: 10.1016/j.schres.2019.02.011. Epub 2019 Feb 22.

PMID:
30799218
19.

Mental health in refugees and asylum seekers (MEHIRA): study design and methodology of a prospective multicentre randomized controlled trail investigating the effects of a stepped and collaborative care model.

Böge K, Karnouk C, Hahn E, Schneider F, Habel U, Banaschewski T, Meyer-Lindenberg A, Salize HJ, Kamp-Becker I, Padberg F, Hasan A, Falkai P, Rapp MA, Plener PL, Stamm T, Elnahrawy N, Lieb K, Heinz A, Bajbouj M.

Eur Arch Psychiatry Clin Neurosci. 2019 Feb 22. doi: 10.1007/s00406-019-00991-5. [Epub ahead of print]

PMID:
30796528
20.

Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine.

Wagner E, Wobrock T, Kunze B, Langguth B, Landgrebe M, Eichhammer P, Frank E, Cordes J, Wölwer W, Winterer G, Gaebel W, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Siskind D, Malchow B, Strube W, Schneider-Axmann T, Falkai P, Hasan A.

Schizophr Res. 2019 Jun;208:370-376. doi: 10.1016/j.schres.2019.01.021. Epub 2019 Jan 29.

PMID:
30704862
21.

Clozapine augmentation strategies - a systematic meta-review of available evidence. Treatment options for clozapine resistance.

Wagner E, Löhrs L, Siskind D, Honer WG, Falkai P, Hasan A.

J Psychopharmacol. 2019 Apr;33(4):423-435. doi: 10.1177/0269881118822171. Epub 2019 Jan 30.

PMID:
30696332
22.

Effects of Aerobic Exercise on Metabolic Syndrome, Cardiorespiratory Fitness, and Symptoms in Schizophrenia Include Decreased Mortality.

Schmitt A, Maurus I, Rossner MJ, Röh A, Lembeck M, von Wilmsdorff M, Takahashi S, Rauchmann B, Keeser D, Hasan A, Malchow B, Falkai P.

Front Psychiatry. 2018 Dec 21;9:690. doi: 10.3389/fpsyt.2018.00690. eCollection 2018. Review.

23.

The influence of religious activity and polygenic schizophrenia risk on religious delusions in schizophrenia.

Anderson-Schmidt H, Gade K, Malzahn D, Papiol S, Budde M, Heilbronner U, Reich-Erkelenz D, Adorjan K, Kalman JL, Senner F, Comes AL, Flatau L, Gryaznova A, Hake M, Reitt M, Schmauß M, Juckel G, Reimer J, Zimmermann J, Figge C, Reininghaus E, Anghelescu IG, Konrad C, Thiel A, von Hagen M, Koller M, Stierl S, Scherk H, Spitzer C, Folkerts H, Becker T, Dietrich DE, Andlauer TFM, Degenhardt F, Nöthen MM, Witt SH, Rietschel M, Wiltfang J, Falkai P, Schulze TG.

Schizophr Res. 2019 Aug;210:255-261. doi: 10.1016/j.schres.2018.12.025. Epub 2019 Jan 3.

PMID:
30611655
24.

Predicting instructed simulation and dissimulation when screening for depressive symptoms.

Goerigk S, Hilbert S, Jobst A, Falkai P, Bühner M, Stachl C, Bischl B, Coors S, Ehring T, Padberg F, Sarubin N.

Eur Arch Psychiatry Clin Neurosci. 2018 Dec 12. doi: 10.1007/s00406-018-0967-2. [Epub ahead of print]

PMID:
30542818
25.

Polygenic analysis suggests the involvement of calcium signaling in executive function in schizophrenia patients.

Kirchner SK, Ozkan S, Musil R, Spellmann I, Kannayian N, Falkai P, Rossner M, Papiol S.

Eur Arch Psychiatry Clin Neurosci. 2018 Dec 7. doi: 10.1007/s00406-018-0961-8. [Epub ahead of print]

PMID:
30523404
26.

Prospective acceptance of distinct mobile mental health features in psychiatric patients and mental health professionals.

Hendrikoff L, Kambeitz-Ilankovic L, Pryss R, Senner F, Falkai P, Pogarell O, Hasan A, Peters H.

J Psychiatr Res. 2019 Feb;109:126-132. doi: 10.1016/j.jpsychires.2018.11.025. Epub 2018 Dec 1.

PMID:
30530207
27.

Neurocognitive and neuroanatomical maturation in the clinical high-risk states for psychosis: A pattern recognition study.

Kambeitz-Ilankovic L, Haas SS, Meisenzahl E, Dwyer DB, Weiske J, Peters H, Möller HJ, Falkai P, Koutsouleris N.

Neuroimage Clin. 2019;21:101624. doi: 10.1016/j.nicl.2018.101624. Epub 2018 Dec 3.

28.

WFSBP guidelines on how to grade treatment evidence for clinical guideline development.

Hasan A, Bandelow B, Yatham LN, Berk M, Falkai P, Möller HJ, Kasper S; WFSBP Guideline Task Force Chairs.

World J Biol Psychiatry. 2019 Jan;20(1):2-16. doi: 10.1080/15622975.2018.1557346. Epub 2019 Feb 4. Review.

PMID:
30526182
29.

Efficient region-based test strategy uncovers genetic risk factors for functional outcome in bipolar disorder.

Budde M, Friedrichs S, Alliey-Rodriguez N, Ament S, Badner JA, Berrettini WH, Bloss CS, Byerley W, Cichon S, Comes AL, Coryell W, Craig DW, Degenhardt F, Edenberg HJ, Foroud T, Forstner AJ, Frank J, Gershon ES, Goes FS, Greenwood TA, Guo Y, Hipolito M, Hood L, Keating BJ, Koller DL, Lawson WB, Liu C, Mahon PB, McInnis MG, McMahon FJ, Meier SM, Mühleisen TW, Murray SS, Nievergelt CM, Nurnberger JI Jr, Nwulia EA, Potash JB, Quarless D, Rice J, Roach JC, Scheftner WA, Schork NJ, Shekhtman T, Shilling PD, Smith EN, Streit F, Strohmaier J, Szelinger S, Treutlein J, Witt SH, Zandi PP, Zhang P, Zöllner S, Bickeböller H, Falkai PG, Kelsoe JR, Nöthen MM, Rietschel M, Schulze TG, Malzahn D.

Eur Neuropsychopharmacol. 2019 Jan;29(1):156-170. doi: 10.1016/j.euroneuro.2018.10.005. Epub 2018 Nov 29.

30.

Serum Insulin and Cognitive Performance in Older Adults: A Longitudinal Study.

Hooshmand B, Rusanen M, Ngandu T, Leiviskä J, Sindi S, von Arnim CAF, Falkai P, Soininen H, Tuomilehto J, Kivipelto M.

Am J Med. 2019 Mar;132(3):367-373. doi: 10.1016/j.amjmed.2018.11.013. Epub 2018 Nov 29.

PMID:
30502316
31.

Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment.

Steiner J, Prüss H, Köhler S, Frodl T, Hasan A, Falkai P.

World J Biol Psychiatry. 2018 Dec 4:1-14. doi: 10.1080/15622975.2018.1555376. [Epub ahead of print]

PMID:
30513253
32.

Self-esteem fully mediates positive life events and depressive symptoms in a sample of 173 patients with affective disorders.

Sarubin N, Goerigk S, Padberg F, Übleis A, Jobst A, Erfurt L, Schumann C, Nadjiri A, Dewald-Kaufmann J, Falkai P, Bühner M, Naumann F, Hilbert S.

Psychol Psychother. 2018 Nov 28. doi: 10.1111/papt.12205. [Epub ahead of print]

PMID:
30488539
33.

Studying and modulating schizophrenia-associated dysfunctions of oligodendrocytes with patient-specific cell systems.

Raabe FJ, Galinski S, Papiol S, Falkai PG, Schmitt A, Rossner MJ.

NPJ Schizophr. 2018 Nov 19;4(1):23. doi: 10.1038/s41537-018-0066-4. Review.

34.

Impaired recovery in affective disorders and schizophrenia: sharing a common pathophysiology?

Falkai P, Schmitt A, Koutsouleris N.

Eur Arch Psychiatry Clin Neurosci. 2018 Dec;268(8):739-740. doi: 10.1007/s00406-018-0951-x. No abstract available.

PMID:
30374704
35.

Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis.

Koutsouleris N, Kambeitz-Ilankovic L, Ruhrmann S, Rosen M, Ruef A, Dwyer DB, Paolini M, Chisholm K, Kambeitz J, Haidl T, Schmidt A, Gillam J, Schultze-Lutter F, Falkai P, Reiser M, Riecher-Rössler A, Upthegrove R, Hietala J, Salokangas RKR, Pantelis C, Meisenzahl E, Wood SJ, Beque D, Brambilla P, Borgwardt S; PRONIA Consortium.

JAMA Psychiatry. 2018 Nov 1;75(11):1156-1172. doi: 10.1001/jamapsychiatry.2018.2165. Erratum in: JAMA Psychiatry. 2019 May 1;76(5):550.

PMID:
30267047
36.

EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH).

Stubbs B, Vancampfort D, Hallgren M, Firth J, Veronese N, Solmi M, Brand S, Cordes J, Malchow B, Gerber M, Schmitt A, Correll CU, De Hert M, Gaughran F, Schneider F, Kinnafick F, Falkai P, Möller HJ, Kahl KG.

Eur Psychiatry. 2018 Oct;54:124-144. doi: 10.1016/j.eurpsy.2018.07.004. Review.

PMID:
30257806
37.

Left prefrontal high-frequency rTMS may improve movement disorder in schizophrenia patients with predominant negative symptoms - A secondary analysis of a sham-controlled, randomized multicenter trial.

Kamp D, Engelke C, Wobrock T, Wölwer W, Winterer G, Schmidt-Kraepelin C, Gaebel W, Langguth B, Landgrebe M, Eichhammer P, Frank E, Hajak G, Ohmann C, Verde PE, Rietschel M, Raees A, Honer WG, Malchow B, Schneider-Axmann T, Falkai P, Hasan A, Cordes J.

Schizophr Res. 2019 Feb;204:445-447. doi: 10.1016/j.schres.2018.09.017. Epub 2018 Sep 22. No abstract available.

PMID:
30249471
38.

Verhaltensauffälliger Patient: was tun?

Falkai P.

MMW Fortschr Med. 2018 Sep;160(15):44. doi: 10.1007/s15006-018-0884-3. Review. German. No abstract available.

PMID:
30206850
39.

[The crying patient].

Winter J, Falkai P, Schüle C.

MMW Fortschr Med. 2018 Sep;160(15):50-53. doi: 10.1007/s15006-018-0887-0. Review. German. No abstract available.

PMID:
30206847
40.

[The speechless patient].

Häckert J, Falkai P, Perneczky R, Pogarell O.

MMW Fortschr Med. 2018 Sep;160(15):53-56. doi: 10.1007/s15006-018-0888-z. Review. German. No abstract available.

PMID:
30206846
41.

Effects of sedative drug use on the dopamine system: a systematic review and meta-analysis of in vivo neuroimaging studies.

Kamp F, Proebstl L, Penzel N, Adorjan K, Ilankovic A, Pogarell O, Koller G, Soyka M, Falkai P, Koutsouleris N, Kambeitz J.

Neuropsychopharmacology. 2019 Mar;44(4):660-667. doi: 10.1038/s41386-018-0191-9. Epub 2018 Aug 27. Review.

PMID:
30188512
42.

A longitudinal approach to biological psychiatric research: The PsyCourse study.

Budde M, Anderson-Schmidt H, Gade K, Reich-Erkelenz D, Adorjan K, Kalman JL, Senner F, Papiol S, Andlauer TFM, Comes AL, Schulte EC, Klöhn-Saghatolislam F, Gryaznova A, Hake M, Bartholdi K, Flatau L, Reitt M, Quast S, Stegmaier S, Meyers M, Emons B, Haußleiter IS, Juckel G, Nieratschker V, Dannlowski U, Schaupp SK, Schmauß M, Zimmermann J, Reimer J, Schulz S, Wiltfang J, Reininghaus E, Anghelescu IG, Arolt V, Baune BT, Konrad C, Thiel A, Fallgatter AJ, Figge C, von Hagen M, Koller M, Lang FU, Wigand ME, Becker T, Jäger M, Dietrich DE, Stierl S, Scherk H, Spitzer C, Folkerts H, Witt SH, Degenhardt F, Forstner AJ, Rietschel M, Nöthen MM, Falkai P, Schulze TG, Heilbronner U.

Am J Med Genet B Neuropsychiatr Genet. 2019 Mar;180(2):89-102. doi: 10.1002/ajmg.b.32639. Epub 2018 Aug 2.

43.

Effects of Three Months of Aerobic Endurance Training on Motor Cortical Excitability in Schizophrenia Patients and Healthy Subjects.

Roeh A, Malchow B, Levold K, Labusga M, Keller-Varady K, Schneider-Axmann T, Wobrock T, Schmitt A, Falkai P, Hasan A.

Neuropsychobiology. 2018 Jul 12:1-8. doi: 10.1159/000489714. [Epub ahead of print]

PMID:
30001538
44.

Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders - CORRIGENDUM.

Oviedo-Salcedo T, de Witte L, Kümpfel T, Kahn RS, Falkai P, Eichhorn P, Luykx J, Hasan A.

Br J Psychiatry. 2018 Sep;213(3):561. doi: 10.1192/bjp.2018.77. Epub 2018 Jul 10.

PMID:
29986772
45.

Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study.

Kalman JL, Papiol S, Forstner AJ, Heilbronner U, Degenhardt F, Strohmaier J, Adli M, Adorjan K, Akula N, Alda M, Anderson-Schmidt H, Andlauer TF, Anghelescu IG, Ardau R, Arias B, Arolt V, Aubry JM, Backlund L, Bartholdi K, Bauer M, Baune BT, Becker T, Bellivier F, Benabarre A, Bengesser S, Bhattacharjee AK, Biernacka JM, Birner A, Brichant-Petitjean C, Budde M, Cervantes P, Chillotti C, Cichon S, Clark SR, Colom F, Comes AL, Cruceanu C, Czerski PM, Dannlowski U, Dayer A, Del Zompo M, DePaulo JR, Dietrich DE, Étain B, Ethofer T, Falkai P, Fallgatter A, Figge C, Flatau L, Folkerts H, Frisen L, Frye MA, Fullerton JM, Gade K, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Gryaznova A, Hake M, Hauser J, Herms S, Hoffmann P, Hou L, Jäger M, Jamain S, Jiménez E, Juckel G, Kahn JP, Kassem L, Kelsoe J, Kittel-Schneider S, Kliwicki S, Klohn-Sagatholislam F, Koller M, König B, Konrad C, Lackner N, Laje G, Landén M, Lang FU, Lavebratt C, Leboyer M, Leckband SG, Maj M, Manchia M, Martinsson L, McCarthy MJ, McElroy SL, McMahon FJ, Mitchell PB, Mitjans M, Mondimore FM, Monteleone P, Nieratschker V, Nievergelt CM, Novák T, Ösby U, Pfennig A, Potash JB, Reich-Erkelenz D, Reif A, Reimer J, Reininghaus E, Reitt M, Ripke S, Rouleau GA, Rybakowski JK, Schalling M, Scherk H, Schmauß M, Schofield PR, Schubert KO, Schulte EC, Schulz S, Senner F, Severino G, Shekhtman T, Shilling PD, Simhandl C, Slaney CM, Spitzer C, Squassina A, Stamm T, Stegmaier S, Stierl S, Stopkova P, Thiel A, Tighe SK, Tortorella A, Turecki G, Vieta E, Veeh J, von Hagen M, Wigand ME, Wiltfang J, Witt S, Wright A, Zandi PP, Zimmermann J, Nöthen M, Rietschel M, Schulze TG.

Bipolar Disord. 2019 Feb;21(1):68-75. doi: 10.1111/bdi.12659. Epub 2018 Jun 28.

46.

Improving working memory in schizophrenia: Effects of 1 mA and 2 mA transcranial direct current stimulation to the left DLPFC.

Papazova I, Strube W, Becker B, Henning B, Schwippel T, Fallgatter AJ, Padberg F, Palm U, Falkai P, Plewnia C, Hasan A.

Schizophr Res. 2018 Dec;202:203-209. doi: 10.1016/j.schres.2018.06.032. Epub 2018 Jun 25.

PMID:
29954701
47.

Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.

Stübner S, Grohmann R, Greil W, Zhang X, Müller-Oerlinghausen B, Bleich S, Rüther E, Möller HJ, Engel R, Falkai P, Toto S, Kasper S, Neyazi A.

Int J Neuropsychopharmacol. 2018 Sep 1;21(9):814-821. doi: 10.1093/ijnp/pyy048.

48.

Psychiatry and psychiatrists: Fourteen core statements.

Galderisi S, Falkai P.

Eur Psychiatry. 2018 Aug;52:136-138. doi: 10.1016/j.eurpsy.2018.05.013. No abstract available.

PMID:
29914673
49.

Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder.

Reinbold CS, Forstner AJ, Hecker J, Fullerton JM, Hoffmann P, Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Benabarre A, Bengesser S, Bhattacharjee AK, Biernacka JM, Birner A, Marie-Claire C, Cervantes P, Chen GB, Chen HC, Chillotti C, Clark SR, Colom F, Cousins DA, Cruceanu C, Czerski PM, Dayer A, Étain B, Falkai P, Frisén L, Gard S, Garnham JS, Goes FS, Grof P, Gruber O, Hashimoto R, Hauser J, Herms S, Jamain S, Jiménez E, Kahn JP, Kassem L, Kittel-Schneider S, Kliwicki S, König B, Kusumi I, Lackner N, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, López Jaramillo CA, MacQueen G, Manchia M, Martinsson L, Mattheisen M, McCarthy MJ, McElroy SL, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Ösby U, Ozaki N, Perlis RH, Pfennig A, Reich-Erkelenz D, Rouleau GA, Schofield PR, Schubert KO, Schweizer BW, Seemüller F, Severino G, Shekhtman T, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Smoller JW, Squassina A, Stamm TJ, Stopkova P, Tighe SK, Tortorella A, Turecki G, Volkert J, Witt SH, Wright AJ, Young LT, Zandi PP, Potash JB, DePaulo JR, Bauer M, Reininghaus E, Novák T, Aubry JM, Maj M, Baune BT, Mitchell PB, Vieta E, Frye MA, Rybakowski JK, Kuo PH, Kato T, Grigoroiu-Serbanescu M, Reif A, Del Zompo M, Bellivier F, Schalling M, Wray NR, Kelsoe JR, Alda M, McMahon FJ, Schulze TG, Rietschel M, Nöthen MM, Cichon S.

Front Psychiatry. 2018 May 31;9:207. doi: 10.3389/fpsyt.2018.00207. eCollection 2018.

50.

The Role of Self-Esteem in Depression: A Longitudinal Study.

Hilbert S, Goerigk S, Padberg F, Nadjiri A, Übleis A, Jobst A, Dewald-Kaufmann J, Falkai P, Bühner M, Naumann F, Sarubin N.

Behav Cogn Psychother. 2019 Mar;47(2):244-250. doi: 10.1017/S1352465818000243. Epub 2018 Apr 25.

PMID:
29692278

Supplemental Content

Loading ...
Support Center